Congenital Uterine Abnormalities

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Last updated: June 3, 2026Bookmark

Congenital anomalies of the uterus occur when the Müllerian ducts fail to form, fail to fuse, or the septum fails to dissolve completely. These abnormalities are characterised by recurrent preterm labour and delivery. More severe abnormalities can manifest earlier in adolescence.

5 – 6% of women have some form of abnormality of their uterus.

Products of the paramesonephric and mesonephric ducts

Structure	Products
Mesonephric ducts (males)	Epididymis, vas deferens, seminal vesicle
Paramesonephric duct (females)	Fallopian tubes, uterus, proximal 1/3 of the vagina

Pathogenesis of Mullerian Anomalies

Anomaly	Pathogenesis
Mullerian agenesis or hypoplasia	Failure of both ducts to form
Unicornuate uterus	Failure of one duct to form
Uterus didelphys	Complete failure of fusion
Bicornuate uterus (partial and complete)	Failure of cranial fusion
Septate uterus (partial or complete)	Failure of septum dissolution
Arcuate uterus	Inconsequential septum
T-shaped (DES) uterus	Teratogenic effects of diethylstillbestrol

Summary of congenital uterine anomalies

Anomaly	Clinical features	Radiological Findings
Müllerian agenesis (MRKH)	Primary amenorrhoea	US/MRI: Absent uterus/vagina (↓ endometrial stripe). Ovaries normal.
Unicornuate uterus	Secondary amenorrhoea, recurrent miscarriage, recurrent preterm delivery, malpresentation and rupture of rudimentary horn	HSG: Single banana-shaped cavity. MRI: Asymmetric, single horn ± rudimentary horn (may communicate).
Uterus didelphys	Recurrent preterm delivery	MRI/US: Two separate uteri, cervices, ± vaginal septum. HSG: Double barrels.
Bicornuate uterus	Recurrent preterm delivery and malpresentation	MRI: Deep fundal cleft (>1 cm), two horns. HSG: Two divergent cavities.
Septate uterus	Recurrent preterm delivery and malpresentation	MRI/3D-US: Flat/concave fundus, septum divides cavity (fibrous/muscular). HSG: V-shaped cavity with a cleft < 1cm
Arcuate uterus	Asymptomatic	MRI/US: Slight fundal indentation (<1 cm). No clinical impact.
T-shaped uterus (DES)	Aymptomatic	HSG/MRI: Narrow cavity, “T” shape, ± constriction bands.

Mesonephric and Paramesonephric ducts
- The paramesonephric (Mullerian) ducts are paired mesodermal structures that form the female reproductive organs.
- In the male testes, sertoli cells produce antimullerian hormone (AMH) which causes the paramesonephric ducts to involute while the mesonephric (Wolffian) ducts develop.
- The lack of antimullerian in women allows the paramesonephric ducts to develop while the mesonephric ducts involute.
- When the mesonephric ducts fail to completely involute in women a gartner duct cyst may arise on the antero-lateral wall of the vagina.
Investigaitions
- 3D Pelvic ultrasound is the best initial test. It is a cost-effective method for evaluating septum length or type.
- Pelvic MRI is the gold standard test for evaluating external fundal contour and neighbouring pelvic organs
- Hysterosalpingography (HSG) is used to visualizes the shape of the uterine cavity and endometrial lining. It may miss rudimentary horns since the dye will not fill non-cavitary or non-communicating horns.

Reference Intervals ›

Biochemistry

ACTH	P: <80 ng/L
ALT	P: 5–35 U/L
Albumin	P: 35–50 g/L
Aldosterone	P: 100–500 pmol/L
Alk. phosphatase	P: 30–130 U/L
α-Amylase	P: 0–180 IU/dL
α-Fetoprotein	S: <10 kU/L
Angiotensin II	P: 5–35 pmol/L
ADH	P: 0.9–4.6 pmol/L
AST	P: 5–35 U/L
Bicarbonate	P: 24–30 mmol/L
Bilirubin	P: 3–17 μmol/L
BNP	P: <50 ng/L
CRP	P: <10 mg/L
Calcitonin	P: <0.1 mcg/L
Calcium (ionized)	P: 1.0–1.25 mmol/L
Calcium (total)	P: 2.12–2.60 mmol/L
Chloride	P: 95–105 mmol/L
Cholesterol	P: <5.0 mmol/L
VLDL	P: 0.128–0.645 mmol/L
LDL	P: <2.0 mmol/L
HDL	P: 0.9–1.93 mmol/L
Cortisol AM	P: 450–700 nmol/L
Cortisol Midnight	P: 80–280 nmol/L
CK ♂	P: 25–195 U/L
CK ♀	P: 25–170 U/L
Creatinine	P: 70–100 μmol/L
Ferritin	P: 12–200 mcg/L
Folate	S: 2.1 mcg/L
FSH	P: 2–8 U/L ♂; >25 menopause
GGT ♂	P: 11–51 U/L
GGT ♀	P: 7–33 U/L
Glucose (fasting)	P: 3.5–5.5 mmol/L
Growth hormone	P: <20 mu/L
HbA1C (DCCT)	B: 4–6%
HbA1C (IFCC)	B: 20–42 mmol/mol
Iron ♂	S: 14–31 μmol/L
Iron ♀	S: 11–30 μmol/L
Lactate (venous)	P: 0.6–2.4 mmol/L
Lactate (arterial)	P: 0.6–1.8 mmol/L
LDH	P: 70–250 U/L
LH	P: 3–16 U/L
Magnesium	P: 0.75–1.05 mmol/L
Osmolality	P: 278–305 mosmol/kg
PTH	P: 0.8–8.5 pmol/L
Potassium	P: 3.5–5.3 mmol/L
Prolactin ♂	P: <450 U/L
Prolactin ♀	P: <600 U/L
PSA	P: 0–4 mcg/mL
Protein (total)	P: 60–80 g/L
Red cell folate	B: 0.36–1.44 μmol/L
Renin (erect)	P: 2.8–4.5 pmol/mL/h
Renin (recumbent)	P: 1.1–2.7 pmol/mL/h
Sodium	P: 135–145 mmol/L
TBG	P: 7–17 mg/L
TSH	P: 0.5–4.2 mU/L
T4	P: 70–140 nmol/L
Free T4	P: 9–22 pmol/L
TIBC	S: 54–75 μmol/L
Triglycerides	P: 0.50–2.3 mmol/L
T3	P: 1.2–3.0 nmol/L
Troponin T	P: <0.1 mcg/L
Urate ♂	P: 210–480 μmol/L
Urate ♀	P: 150–390 μmol/L
Urea	P: 2.5–6.7 mmol/L
Vitamin B12	S: 0.13–0.68 nmol/L
Vitamin D	S: 50 nmol/L

Arterial Blood Gases

pH	7.35–7.45
PaCO₂	4.7–6.0 kPa
PaO₂	>10.6 kPa
Base excess	±2 mmol/L

Urine

Cortisol (free)	<280 nmol/24h
Hydroxyindole acetic acid	16–73 μmol/24h
Hydroxymethylmandelic acid	16–48 μmol/24h
Metanephrines	0.03–0.69 μmol/mmol cr.
Osmolality	350–1000 mosmol/kg
17-Oxogenic steroids ♂	28–30 μmol/24h
17-Oxogenic steroids ♀	21–66 μmol/24h
17-Oxosteroids ♂	17–76 μmol/24h
17-Oxosteroids ♀	14–59 μmol/24h
Phosphate (inorganic)	15–50 mmol/24h
Potassium	14–120 mmol/24h
Protein	<150 mg/24h
Protein/creatinine ratio	<3 mg/mmol
Sodium	100–250 mmol/24h

Haematology

WCC	4.0–11.0 ×10⁹/L
RBC ♂	4.5–6.5 ×10¹²/L
RBC ♀	3.9–5.6 ×10¹²/L
Hb ♂	130–180 g/L
Hb ♀	115–160 g/L
PCV ♂	0.4–0.54 L/L
PCV ♀	0.37–0.47 L/L
MCV	76–96 fL
MCH	27–32 pg
MCHC	300–360 g/L
RDW	11.6–14.6%
Neutrophils	2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes	1.0–4.5 ×10⁹/L (20–45%)
Eosinophils	0.04–0.44 ×10⁹/L (1–6%)
Basophils	0–0.10 ×10⁹/L (0–1%)
Monocytes	0.2–0.8 ×10⁹/L (2–10%)
Platelets	150–400 ×10⁹/L
Reticulocytes	0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time	10–14 s
APTT	35–45 s

Paediatric

Pulse Rate (bpm)
Neonate	140–160
Infant <1yr	120–140
1–5 years	110–130
5–12 years	80–120
>12 years	70–100
Respiratory Rate (tachypnoea)
0–2 months	≥60/min
2–12 months	≥50/min
1–5 years	≥40/min
>5 years	≥30/min
Blood Pressure (mmHg)
Term	65/45
1 year	75/50
4 years	85/60
8 years	95/65
10 years	100/70
Weight Formulas
3–12 months	(a + 9)/2 kg
1–6 years	2a + 8 kg
>6 years	(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn	13–20
1 month	11–18
2 months	10–15
1–2 years	10–13
>2 years	11–14
MUAC (6 months–5 years)
Obese	>17.5 cm
Normal	13.5–17.4 cm
At risk	12.5–13.4 cm
Moderate malnutrition	11.5–12.4 cm
Severe malnutrition	<11.5 cm
Developmental Milestones
Social smile	1.5 months
Head control	4 months
Sits unsupported	7 months
Crawls	10 months
Stands unsupported	10–12 months
Walks	12–13 months
Talks	18 months
CSF WBC (/mm³)
Term newborn	0–25
>2 weeks	0–5

Calculator ›

Leave a ReplyCancel Reply